NCT06440226

Brief Summary

This study investigates the impact of lucid dreaming on individuals and explores methods to increase the likelihood of inducing lucid dreams intentionally. This study explores the impact of lucid dreaming on individuals, examining how this unique state of consciousness affects mental and emotional well-being. It further explores various methods aimed at increasing the likelihood of intentionally inducing lucid dreams. By analyzing scientific literature and experimental findings, the research highlights the potential therapeutic and creative benefits of lucid dreaming. Additionally, the study offers practical techniques designed to enhance the frequency of lucid dreams, such as maintaining a dream journal, eye movement before sleep, and recall of memories. These approaches provide individuals with tools to harness the power of lucid dreaming for personal growth and self-discovery.This study highlights the potential benefits of lucid dreaming and provides practical techniques for enhancing its frequency.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 9, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 26, 2024

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2024

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

May 21, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 3, 2024

Completed
Last Updated

June 3, 2024

Status Verified

May 1, 2024

Enrollment Period

4 months

First QC Date

May 21, 2024

Last Update Submit

May 28, 2024

Conditions

Keywords

sleepsleep disorderlucid dreamingdreamssleep hygiene

Outcome Measures

Primary Outcomes (1)

  • Testing the likelihood of Lucid Dreaming in Participants

    Measuring the likelihood of lucid dreaming with the implementation of the methods mentioned in the behavioural section of this study.

    4 months

Study Arms (3)

Placebo Group

Detailed in study, no dosages, no drugs used.

Actual Group

Detailed in study, no dosages, no drugs used.

Behavioral: Eye Movement TechniqueBehavioral: Memory Recall of Previous Night's ThoughtsBehavioral: Recall of Previous Lucid Dreams

Standard Assessment Group

Detailed in study, no dosages, no drugs used.

Interventions

Participants were instructed to move their eyes as much as possible with their eyes closed just before falling asleep. This technique aimed to mimic the Rapid Eye Movement (REM) sleep phase, which is often associated with more vivid and memorable dreams.

Actual Group

Another intervention involved asking participants to recall and think about their thoughts or events from the previous night before going to sleep. This method engaged cognitive processes related to memory and reflection, potentially setting the stage for increased awareness during sleep.

Actual Group

Participants were also asked to recall their lucid dreams from previous nights. This intervention seemed to activate memory and awareness related to dreaming, which significantly increased the likelihood of experiencing lucid dreams the following night.

Actual Group

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Young, healthy, individuals with no previous record of medical sleep conditions.

You may qualify if:

  • Normal blood pressure, Healthy weight, no record of sleep apnea, no difficulty sleeping, ages between 18-30 only.

You may not qualify if:

  • Overweight(muscle being taken into consideration, not using BMI), high or low blood pressure,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Reserology Research

London, DN3 6GB, United Kingdom

Location

Related Publications (1)

  • Greenwald B, Lombard LA, Watanabe TK. Managing sleepiness after traumatic brain injury. PM R. 2011 May;3(5):480-5. doi: 10.1016/j.pmrj.2011.04.010. No abstract available.

Biospecimen

Retention: SAMPLES WITH DNA

All records of participants and randomly selected individuals are kept.

MeSH Terms

Conditions

Sleep Wake DisordersSleep Hygiene

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersHealth BehaviorBehavior

Study Officials

  • Abdelraheem Mohamed

    Reserology Research Foundation

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Director

Study Record Dates

First Submitted

May 21, 2024

First Posted

June 3, 2024

Study Start

January 9, 2024

Primary Completion

April 26, 2024

Study Completion

May 2, 2024

Last Updated

June 3, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Privacy reasons as requested by participants when signed up contractually.

Locations